FY27 Lenalidomide BPA

Updated Oct 31, 2026

Sources Sought from the Department of Veterans Affairs. Due Nov 12, 2026, 10:00 AM (UTC-8), 12 days left.

Bid documents (1)

• Bid document 22 KB

Paid members download every document from this page, or buy this bid alone.

Description

This request for information (RFI) / sources sought notice is issued solely for information and planning purposes. THIS IS NOT A SOLICITATION. Submission of information about pricing, delivery, the market, and capabilities is highly encouraged and allowed under this RFI for planning purposes in accordance with (IAW) FAR 15.201(e).

DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract.

Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only.

The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published.

The Department of Veterans Affairs (VA) is seeking sources capable of providing Lenalidomide medication in multiple dosage strengths. STATEMENT OF WORK LENALIDOMIDE MEDICATION Introduction The Department of Veterans Affairs requires a Health Service Area (HSA) 5.3 Blanket Purchase Agreement (BPA) for Lenalidomide. Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers.

Contractor is to provide Lenalidomide and deliver to participating HSA 5.3 VA Medical Centers (VAMCs). Participating HSA 5.3 VAMCs: VA Albuquerque Healthcare System (501) 1501 San Pedro Drive SE Albuquerque, NM 87108 VA Long Beach Healthcare System (600) 5901 East 7th Street Long Beach, CA 90822 VA Loma Linda Healthcare System (605) 11201 Benton Street Loma Linda, CA 92357 VA Phoenix Healthcare System (644) 650 E Indian School Road Phoenix, AZ 85012 VA Prescott Healthcare System (649) 500 N. State Highway 89 Prescott, AZ 86313 VA San Diego Healthcare System (664) 3350 La Jolla Village Drive San Diego, CA 92161 VA Tucson Healthcare System (678) 3601 S 6th Avenue Tucson, AZ 85723 VA Greater Los Angeles Healthcare System (691) 11301 Wilshire Blvd Los Angeles, CA 90073 Ordering Participating VA Medical Centers shall place orders through an approved purchase order (PO) per station.

An approved purchase order shall be signed by a warranted Contracting Officer (CO). Dispensing: Lenalidomide is under Food and Drug Administration s Risk Evaluation and Mitigation Strategy (REMS) program. The contractor must hold REMS certification to dispense.

Schedule of Supplies: Line Item Description 0001 LENALIDOMIDE 2.5MG CAP,ORAL 0002 LENALIDOMIDE 5MG CAP,ORAL 0003 LENALIDOMIDE 10MG CAP,ORAL 0004 LENALIDOMIDE 15MG CAP,ORAL 0005 LENALIDOMIDE 20MG CAP,ORAL 0006 LENALIDOMIDE 25MG CAP,ORAL Station Estimated number of patients on FY 26 501 14 600 27 605 18 644 32 649 13 664 28 678 30 691 26 There is not a contractual statement of precise quantities that the Government will order under this BPA.

The Government will only pay for quantities that are actually ordered and for which services are fulfilled of each delivery order per station. Above estimated number for patients is based on historical data from previous years. As the required dosage will vary depending on individual patient and provider decisions, the Government is unable to specify the exact quantity needed for each dosage.

The contractor is to provide pricing for all dosage strengths, and each station will place orders as needed at the prices negotiated under this contract. Period of Performance: 1-year after award Delivery: The contractor shall be responsible for the delivery of medication to specified location upon ordering in accordance with the requirements outlined. The medication should be provided in the required quantities and formulation as specified.

The contractor must ensure proper handling, storage, and transportation conditions (temperature control if required) of the medication to maintain its integrity and compliance with all applicable regulations. Payments: Payments shall be made upon delivery and acceptance by individual medical centers. The contractor shall use the purchase order (PO) number when submitting for payment through Tungsten network website portal.tungsten-network.com.

The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements.

For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement. (2) Please review the list of SOW requirements and provide any additional feedback or suggestions.

If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in th

The description continues in the official notice.

Contracting contact

• Hestia Sim · Contracting Officer · [email protected]

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 325412, a business counts as small if it has no more than 1,300 employees (SBA size standard). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for pharmaceutical preparation manufacturing work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.

• Mckesson Corporation $12.3 billion in this trade
• Exelan Pharmaceuticals Inc $97.1 million in this trade
• Progenics Pharmaceuticals Inc $40.8 million in this trade
• Novartis Pharmaceuticals Corporation $39.9 million in this trade
• Trillamed LLC $1.1 million in this trade

About the buyer

The Department of Veterans Affairs awarded $84.6 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.

Pharmaceutical Preparation Manufacturing contracts right now

There are 22 open government contract opportunities in this trade (NAICS 325412), 7 posted in the last 7 days; 9% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Logistics Agency and Department of State. Most of the work with a stated place is in Pennsylvania, Texas and North Carolina. A notice in this trade gives a median of 18 days from posting to deadline; this one gives 13 days.

All open pharmaceutical preparation manufacturing contracts

Coming up in this trade

Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.

Recent awards in this trade

• Novartis Pharmaceuticals Corporation $769,497 · Department of Veterans Affairs · Oct 29, 2026
• Nuclear Diagnostic Products Of Philadelphia, Inc $1.2 million · Department of Veterans Affairs · Oct 29, 2026
• Alembic Therapeutics LLC $475,000 · Department of Veterans Affairs · Oct 26, 2026
• Avkare LLC $1.6 million · Department of Veterans Affairs · Oct 23, 2026
• Novartis Pharmaceuticals Corporation $3.1 million · Department of Veterans Affairs · Oct 1, 2026

From the award notices agencies publish.

Similar open pharmaceutical preparation manufacturing bids